Current Edition

clinical

miRagen Announces Initiation of Phase 1 Clinical Trial of MRG-110

miRagen Therapeutics, Inc, a clinical-stage biopharmaceutical company focused on the discovery and development of RNA-targeted therapies, announced today the initiation of a Phase 1 clinical …

Continue Reading →